Viewing StudyNCT04456673



Ignite Creation Date: 2024-05-06 @ 2:53 PM
Last Modification Date: 2024-10-26 @ 1:39 PM
Study NCT ID: NCT04456673
Status: COMPLETED
Last Update Posted: 2024-03-25
First Post: 2020-06-30

Brief Title: Pivotal Study to Assess the Efficacy Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation
Sponsor:
Organization: Sanofi